Defective Fe Metal-Organic Frameworks Enhance Metabolic Profiling for High-Accuracy Diagnosis of Human Cancers

© 2022 Wiley-VCH GmbH.

Détails bibliographiques
Publié dans:Advanced materials (Deerfield Beach, Fla.). - 1998. - 34(2022), 26 vom: 15. Juli, Seite e2201422
Auteur principal: Yang, Jing (Auteur)
Autres auteurs: Yin, Xia, Zhang, Longzhou, Zhang, Xiwen, Lin, Yue, Zhuang, Linzhou, Liu, Wanshan, Zhang, Ru, Yan, Xuecheng, Shi, Li, Di, Wen, Feng, Lei, Jia, Yi, Wang, Jinlan, Qian, Kun, Yao, Xiangdong
Format: Article en ligne
Langue:English
Publié: 2022
Accès à la collection:Advanced materials (Deerfield Beach, Fla.)
Sujets:Journal Article cancer diagnostics mass spectrometry metabolites metal-organic frameworks Metal-Organic Frameworks Metals
Description
Résumé:© 2022 Wiley-VCH GmbH.
Cancers heavily threaten human life; therefore, a high-accuracy diagnosis is vital to protect human beings from the suffering of cancers. While biopsies and imaging methods are widely used as current technologies for cancer diagnosis, a new detection platform by metabolic analysis is expected due to the significant advantages of fast, simple, and cost-effectiveness with high body tolerance. However, the signal of molecule biomarkers is too weak to acquire high-accuracy diagnosis. Herein, precisely engineered metal-organic frameworks for laser desorption/ionization mass spectrometry, allowing favorable charge transfer within the molecule-substrate interface and mitigated thermal dissipation by adjusting the phonon scattering with metal nodes, are developed. Consequently, a surprising signal enhancement of ≈10 000-fold is achieved, resulting in diagnosis of three major cancers (liver/lung/kidney cancer) with area-under-the-curve of 0.908-0.964 and accuracy of 83.2%-90.6%, which promises a universal detection tool for large-scale clinical diagnosis of human cancers
Description:Date Completed 04.07.2022
Date Revised 05.07.2022
published: Print-Electronic
Citation Status MEDLINE
ISSN:1521-4095
DOI:10.1002/adma.202201422